Calder A

Molecular Psychiatry Lab, Faculty of Science and Medicine, University of Fribourg, Villars-sur-Glâne, Switzerland.

5 papers · 1 preprint · ORCID

ArticlePsilocybin

Adverse Effect-Related Language in Recreational Psychedelic and non-Psychedelic Substance Experience Reports.

Hase A, Erdmann M, Calder A +4

Europe PMC2026
ArticlePsilocybin

Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.

Beichmann K, Catzeflis P, Aicher HD +4

Europe PMC2026
PreprintMDMA

Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA

Calder A, Hasler G

Europe PMC2024
ArticlePsychedelics

Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy.

Calder A, Hasler G

Europe PMC2023
ArticlePsilocybin

Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.

Calder A, Mock S, Friedli N +2

Europe PMC2023
ArticlePsychedelics

Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.

Ponomarenko P, Seragnoli F, Calder A +2

Europe PMC2023